A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Clinical trial NCT00576732 · COMPLETED
Trial details
- NCT number
- NCT00576732
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2009-09-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.